News & EventsLearn more about ReForm Biologics and our commitment to innovation in biotherapeutics.
BioProcess International Conference – September 25-28, 2017
ReForm Biologics will present a talk entitled “A Novel Excipient for High-Concentration Protein Formulations” in the “Drug Product, Fill-Finish & Formulations” track at BioProcess International Conference on September 28th at the Hynes Convention Center in Boston. Conference details are available at: https://lifesciences.knect365.com/bioprocessinternational/.
BioPharm America 2017, Boston – September 26-27, 2017
Please arrange a meeting through the partnering system at BioPharm America 2017.
The Bioprocessing Summit – August 21-25, 2017
ReForm Biologics will present a poster with details of a new excipient study for surfactant replacement in the “Overcoming Formulation Challenges for Biopharmaceutical Development” track at The Bioprocessing Summit, taking place August 21-25, 2017 at the Westin Copley Place in Boston. Conference details are available at: http://www.bioprocessingsummit.com/
ReForm Biologics Announces Issuance of U.S. Patent for New Excipient to Improve Antibody-Based Therapeutics
ReForm Biologics to present at the 13th annual PEGS Summit
ReForm Biologics, a pharmaceutical technology company developing an innovative platform to improve biologic formulations, announced today the issuance of U.S. patent 9,605,051 (the ‘051 patent) for one of its new excipient formulations.
ReForm Biologics Appoints John M. Sorvillo, Ph.D., as Chief Executive Officer
Dr. Sorvillo brings over 25 years of experience leading the development and licensing of technologies, from discovery platforms and research programs to pre-clinical and clinical products, across a range of therapeutic areas.